Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

US FDA Approves First 'Artificial Pancreas' In Medtronic's MiniMed 670G

Executive Summary

The hybrid closed-loop automated insulin delivery system, the first closed-loop system approved anywhere in the world, automatically monitors glucose and provides appropriate basal insulin doses in people with type 1 diabetes.


Related Content

New Products Drive Medtronic’s Revenue, Profit Growth In Q3
US Approvals Analysis: Strong Q3 For Metabolic-Disease Devices
Abbott Gains US Approval For Pro Version Of Flash Glucose System
From Pipe Dream To Reality: Artificial Pancreas Set To Debut
Medtronic Gets Extra FDA Attention To Hasten Approval Of Next-Gen Insulin Pump


Related Companies